MedTrace Logo

Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)

NCT03498248 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 155

Last updated 2018-04-13

No results posted yet for this study

Summary

The purpose of this study was to analyze the clinical factors associated with the effect of Granulocyte-Colony Stimulating Factor (G-CSF).

Conditions

Interventions

DRUG

lenograstim

injection of lenograstim in patients with neutropenia after cytotoxic chemotherapy

Sponsors & Collaborators

  • DERSHENG SUN

    lead OTHER

Principal Investigators

  • Yoon Ho Ko · Uijeongbu St. Mary's Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-19
Primary Completion
2018-08-31
Completion
2019-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03498248 on ClinicalTrials.gov